Liberum Capital Reaffirms “Buy” Rating for Medicx Fund (MXF)

Liberum Capital reissued their buy rating on shares of Medicx Fund (LON:MXF) in a research report released on Wednesday morning.

Separately, Peel Hunt reiterated a reduce rating on shares of Medicx Fund in a report on Monday, July 23rd.

Shares of LON MXF opened at GBX 0.77 ($0.01) on Wednesday. Medicx Fund has a 1-year low of GBX 76.75 ($1.00) and a 1-year high of GBX 92.50 ($1.20).

The firm also recently announced a dividend, which will be paid on Friday, September 28th. Investors of record on Thursday, August 16th will be issued a GBX 1.51 ($0.02) dividend. The ex-dividend date of this dividend is Thursday, August 16th. This represents a dividend yield of 1.88%.

Medicx Fund Company Profile

MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 154 properties.

Featured Story: Stock Symbol

Receive News & Ratings for Medicx Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicx Fund and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply